Stock listing
NYSE:DNA Genentech Inc Stock
Follow Genentech Inc into a list and get an email when it puts out news.
Last close · NYSE:DNA
$94.97 USD
Close on Mar 26, 2009 · No longer trades
- Lowest – highest close
- $7.45 – $99.66 USDSince Dec 31, 1997 · lowest Jan 6, 1998 · highest Dec 5, 2005
Delisted NYSE:DNA no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NYSE:DNA
- Asset type
- Stock
- Exchange
- NYSE
- Currency
- USD
Genentech Inc on 6ix
- Decks
- 2 decks · latest Nov 17, 2006
Events
| Quarter | Results | Share move |
|---|---|---|
| Quarter to Sep 30, 2026 | Nov 5, 2026 · After close | +13.3% |
| Quarter to Jun 30, 2026 | Aug 5, 2026 · After close | −9.3% |
| Quarter to Mar 31, 2026 | May 7, 2026 · After close | −13.5% |
| Quarter to Dec 31, 2025 | Feb 26, 2026 | −28.0% |
| Quarter to Sep 30, 2025 | Nov 6, 2025 · After close | −20.8% |
| Quarter to Jun 30, 2025 | Aug 7, 2025 · After close | −8.7% |
| Quarter to Mar 31, 2025 | May 6, 2025 · After close | +14.7% |
| Quarter to Dec 31, 2024 | Feb 25, 2025 | −12.9% |
| Quarter to Sep 30, 2024 | Nov 12, 2024 · After close | +2.5% |
| Quarter to Jun 30, 2024 | Aug 8, 2024 · After close | −5.6% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Quarter to Mar 31, 2024 | May 9, 2024 · After close | −17.3% |
| Quarter to Dec 31, 2023 | Feb 29, 2024 · After close | −15.1% |
| Quarter to Sep 30, 2023 | Nov 8, 2023 · After close | −15.4% |
| Quarter to Jun 30, 2023 | Aug 9, 2023 · After close | −12.9% |
| Quarter to Mar 31, 2023 | May 10, 2023 · After close | −1.5% |
| Quarter to Dec 31, 2022 | Mar 1, 2023 · After close | 0.0% |
| Quarter to Sep 30, 2022 | Nov 14, 2022 · After close | −0.4% |
| Quarter to Jun 30, 2022 | Aug 15, 2022 · After close | +7.2% |
| Quarter to Mar 31, 2022 | May 16, 2022 · After close | +12.8% |
| Quarter to Dec 31, 2021 | Mar 28, 2022 · After close | +22.7% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Merger or Acquisition (November 2006) | Merger or acquisition | 19 slides | Nov 17, 2006 |
| Merger or Acquisition (November 2006) | Merger or acquisition | 26 slides | Nov 15, 2006 |
Cap table
Built by 6ix from Genentech Inc’s releases
- Common shares
- 55,383,808
- Fully diluted
- 55,383,808
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 55,383,808 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 55,383,808 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Ian T. Clark Other companies: Takeda Pharmaceutical Co. Ltd. (Director · Since at least Mar 18, 2026); BioMarin Pharmaceutical Inc. (Chair of the Board, · Since at least Aug 1, 2025); GoodRx Holdings, Inc. (Director · Since at least Jul 8, 2024); Kyverna Therapeutics, Inc. (Independent Director · Since at least Feb 7, 2024); Olema Pharmaceuticals, Inc. (Director · Since at least Aug 12, 2020); Guardant Health, Inc. (Director · Since at least Oct 3, 2018); Corvus Pharmaceuticals, Inc. (Director · Since at least Jan 3, 2017); Forty Seven Inc (Director · Jun 27, 2018 – Apr 7, 2020 · Past); Tectonic Therapeutic, Inc. (Director · Jun 20, 2018 – Jun 6, 2023 · Past); Kite Pharma Inc (Director · Jan 3, 2017 – Oct 3, 2017 · Past); Agios Pharmaceuticals, Inc. (Director · Dec 30, 2016 – May 20, 2022 · Past); Terravia Holdings Inc (Director · May 26, 2011 – May 22, 2017 · Past); Dendreon Corp (Director · Oct 7, 2009 – Aug 20, 2010 · Past) | EVP-COMMERCIAL · Sep 20, 2006 – Mar 26, 2009 · Past |
| Debra L Reed Other companies: Lockheed Martin Corporation (Director · Since at least Nov 1, 2019); Chevron Corporation (Director · Since at least Dec 4, 2018); Caterpillar, Inc. (Director · Since at least Jun 10, 2015); DBA Sempra (Chairman, Director · Apr 3, 2010 – Nov 9, 2018 · Past); Avery Dennison Corporation (Director · Oct 22, 2009 – Aug 12, 2011 · Past); Halliburton Company (Director · Aug 1, 2006 – Aug 1, 2018 · Past); Pacific Enterprises Inc (President and COO, Director · Jan 1, 2006 – Jan 1, 2006 · Past) | Director · Apr 20, 2006 – Mar 26, 2009 · Past |
| Charles A Sanders Other companies: LipoScience Inc (Director · Jan 24, 2013 – Jan 30, 2013 · Past); BioCryst Pharmaceuticals, Inc. (Director · Dec 8, 2009 – Feb 29, 2016 · Past); Cephalon Inc (Director · May 12, 2009 – May 20, 2010 · Past); Vertex Pharmaceuticals Incorporated (Director · May 4, 2009 – Jun 1, 2010 · Past); Icagen Inc (Director · Mar 5, 2009 – Sep 2, 2011 · Past); Albireo Pharma Inc (Director · Mar 3, 2009 – Mar 8, 2012 · Past) | Director · Mar 26, 2009 – Mar 26, 2009 · Past |
| Patrick Yang Other companies: Sana Biotechnology, Inc. (Director · Since at least Feb 3, 2021); Amyris Inc (Director · Jul 1, 2014 – Aug 5, 2020 · Past); Eiger Biopharmaceuticals Inc (Director · Mar 2, 2014 – May 20, 2014 · Past); Codexis, Inc. (Director · Feb 22, 2014 – Jun 14, 2022 · Past); Andeavor (Director · Dec 8, 2010 – Oct 1, 2018 · Past) | EVP, Product Operations · Mar 26, 2009 – Mar 26, 2009 · Past |
| Harold Hal Barron Other companies: Quantinuum Inc. (Independent Director · Since at least Jun 4, 2026); Juno Therapeutics Inc (Director · Dec 18, 2014 – Mar 5, 2018 · Past); Alexza Pharmaceuticals Inc (Director · Dec 19, 2007 – May 21, 2013 · Past) | SVP - DEVELOPMENT & CMO · Dec 18, 2007 – Mar 26, 2009 · Past |
Log in to ask 6ix AI your own questions about Genentech Inc.